We confirmed the expression of p16INK4A in DFBM-Ni17/tetp16INK4A tumors upon doxycycline administration to the tumor-bearing mice (Fig. 3d, Supplementary Fig. 4a). The gene discussed is CDKN2A; the disease is neoplasm.